CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 55.670
AS - Asia 26.199
EU - Europa 23.908
SA - Sud America 4.594
Continente sconosciuto - Info sul continente non disponibili 585
AF - Africa 483
OC - Oceania 35
Totale 111.474
Nazione #
US - Stati Uniti d'America 54.659
GB - Regno Unito 9.104
CN - Cina 7.713
SG - Singapore 7.173
IT - Italia 3.978
HK - Hong Kong 3.858
BR - Brasile 3.575
VN - Vietnam 2.684
DE - Germania 2.326
SE - Svezia 1.876
UA - Ucraina 1.840
FI - Finlandia 1.414
KR - Corea 1.034
BD - Bangladesh 961
RU - Federazione Russa 957
TR - Turchia 927
FR - Francia 896
BG - Bulgaria 666
CA - Canada 489
IN - India 447
AR - Argentina 382
ID - Indonesia 266
MX - Messico 200
IQ - Iraq 183
EC - Ecuador 180
NL - Olanda 142
ZA - Sudafrica 132
CO - Colombia 130
PK - Pakistan 111
ES - Italia 108
JP - Giappone 107
VE - Venezuela 98
PL - Polonia 94
AE - Emirati Arabi Uniti 93
IE - Irlanda 92
MA - Marocco 84
CL - Cile 81
PH - Filippine 75
MY - Malesia 66
JM - Giamaica 63
SA - Arabia Saudita 62
CR - Costa Rica 55
LT - Lituania 54
EG - Egitto 53
PY - Paraguay 53
KE - Kenya 52
UZ - Uzbekistan 51
IR - Iran 47
BE - Belgio 41
TN - Tunisia 40
PE - Perù 38
NP - Nepal 35
JO - Giordania 33
PT - Portogallo 33
UY - Uruguay 33
KZ - Kazakistan 30
CH - Svizzera 29
RO - Romania 29
TH - Thailandia 29
AU - Australia 28
HN - Honduras 28
AZ - Azerbaigian 27
DK - Danimarca 27
DZ - Algeria 26
DO - Repubblica Dominicana 25
TT - Trinidad e Tobago 25
EU - Europa 24
AL - Albania 23
IL - Israele 23
NI - Nicaragua 22
AT - Austria 21
GT - Guatemala 21
BO - Bolivia 19
CZ - Repubblica Ceca 18
PR - Porto Rico 18
GR - Grecia 17
RS - Serbia 17
OM - Oman 16
BH - Bahrain 15
BY - Bielorussia 15
ET - Etiopia 15
TW - Taiwan 15
KG - Kirghizistan 14
LB - Libano 14
SC - Seychelles 14
GE - Georgia 13
PA - Panama 13
QA - Qatar 13
SV - El Salvador 13
PS - Palestinian Territory 12
SI - Slovenia 12
BB - Barbados 11
BA - Bosnia-Erzegovina 10
HR - Croazia 10
HU - Ungheria 10
SN - Senegal 10
NG - Nigeria 9
SK - Slovacchia (Repubblica Slovacca) 9
AM - Armenia 8
CY - Cipro 8
Totale 110.749
Città #
Southend 7.074
Ashburn 6.834
Singapore 4.353
Santa Clara 4.098
Jacksonville 4.050
Hong Kong 3.801
Fairfield 3.614
Dearborn 2.599
Hefei 2.590
Woodbridge 2.284
Chandler 2.083
Council Bluffs 1.985
San Jose 1.984
Houston 1.779
Beijing 1.494
Wilmington 1.488
London 1.422
Seattle 1.264
Ann Arbor 1.236
Cambridge 1.152
Nyköping 1.120
Seoul 985
Ho Chi Minh City 907
The Dalles 874
Los Angeles 809
Princeton 763
Helsinki 758
Sofia 656
Eugene 640
Hanoi 639
Dallas 609
Modena 608
New York 594
Lauterbourg 553
Milan 538
Chicago 470
Columbus 468
Buffalo 455
Izmir 428
Bremen 423
São Paulo 418
San Diego 381
Shanghai 283
Moscow 243
Rome 205
Des Moines 188
Salt Lake City 157
Atlanta 131
Guangzhou 125
Orem 125
Haiphong 120
Toronto 119
San Francisco 112
Norwalk 110
Da Nang 106
Miano 102
Rio de Janeiro 99
Frankfurt am Main 92
Phoenix 92
Jakarta 89
Kunming 87
Brooklyn 85
Tampa 83
Dublin 82
Denver 81
Montreal 78
Nanjing 78
Tokyo 78
Philadelphia 74
Boardman 73
Bologna 69
Baghdad 67
Belo Horizonte 67
Brasília 65
Charlotte 65
Curitiba 64
Elk Grove Village 63
Quito 61
Chennai 59
Mexico City 57
Naples 57
Amsterdam 55
Washington 54
Guayaquil 53
Munich 53
San Mateo 52
Biên Hòa 51
Johannesburg 51
Dhaka 50
Hải Dương 50
North Bergen 49
Tashkent 49
Manchester 47
Miami 47
Boston 46
Campinas 45
Verona 45
Warsaw 45
Falls Church 44
Dubai 43
Totale 76.200
Nome #
Diurnal variation of semen quality in human males. 744
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 607
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 589
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 437
Intensity of menstrual pain and estimated angle of uterine flexion 427
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 424
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 420
Pulsatile luteinizing hormone release in postmenopausal women: effect of chronic bromocriptine administration. 401
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 400
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 370
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 368
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 366
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 363
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 361
Adenomyosis of the Extrapelvic Portion of the Round Ligament 351
Intermenstrual pelvic pain, quality of life and mood 349
Association between urinary incontinence and climacteric symptoms in postmenopausal women 348
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 344
Pharmacokinetic evaluation of desogestrel as a female contraceptive 338
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 338
Treatment of menopausal symptoms: concomitant modification of cortisol 334
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 332
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 329
Metabolic impact of combined hormonal contraceptives containing estradiol 327
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 326
Folate administration decreases oxidative status and blood pressure in postmenopausal women 326
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 321
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 321
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 320
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 316
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 312
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 312
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 311
Season of birth influences the timing of menopause 307
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 305
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 304
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 303
Melatonin in relation to physiology in adult humans 302
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 299
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 295
Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens [Aspetti farmacologici, metabolici e clinici delle nuove associazioni contraccettive a base di estrogeni naturali] 294
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 294
Recommendations for contraception in women with diabetes. AMD-SIC position paper 293
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 293
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 291
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 289
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 289
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 287
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 284
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 284
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 281
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 280
Prolonged melatonin administration decreases nocturnal blood pressure in women 277
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 277
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 276
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 271
Medical and patient attitude towards vaginal atrophy: the AGATA study 270
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 269
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 268
Prevalence of menstrual pain in young women: What is dysmenorrhea? 268
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 266
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 265
A role for melatonin in PCOS? 264
Amplification of pulsatile LH secretion by exogenous melatonin in women. 264
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 264
Postmenopausal osteoporosis: relation with folates, vitamin B12 and Homocysteine 261
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 261
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 257
Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. 256
Melatonin enhances cortisol levels in aged but not young women. 256
Oral contraceptive containing drospirenone and 24-hour ambulatory blood pressare. Preliminare data from a prospective study 255
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 255
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement. 255
Drospirenone: dati di sicurezza a lungo termine 254
Anello Contraccettivo: i vantaggi della somministrazione vaginale 252
Contraccettivi con soli progestinici in perimenopausa.Effetti sul dispendio energetico e composizione corporea 252
Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome. 252
Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones 252
Modification of circadian body temperature rhythm during the luteal menstrual phase: role of melatonin. 251
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 250
The effect of tibolone on 24h blood pressure and heart rate 249
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 248
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. 246
Effetti dell’ HRT e SERM sulla pressione arteriosa 246
European society of contraception statement on contraception in obese women 246
Effetto di una terapia ormonale sostitutiva combinata continua contenente noretisterone acetato e del tibolone sulla pressione arteriosa delle 24 h ore 245
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 245
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 244
Hormone replacement therapy and glucose metabolism 244
Seasonal trend of acute pelvic inflammatory disease 244
Cardiovascular effect of transdermal estradiol therapy 244
Role of melatonin in circadian rhythm at menopause 243
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 243
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 243
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. 242
Incremento Ponderale e Modificazioni del Metabolismo Glucidico 242
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 242
A comparison of the central effects of different progestins used in hormone replacement therapy 242
Correlazione tra i livelli di omocisteina e densità minerale ossea in donne in postmenopausa. Uno studio longitudinale 241
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 241
Totale 30.304
Categoria #
all - tutte 417.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 417.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.077 0 0 0 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/202515.613 486 186 115 1.142 3.078 2.003 936 720 2.249 1.091 1.169 2.438
2025/202629.749 1.457 1.520 3.988 4.026 2.537 1.818 3.289 1.888 2.599 3.017 2.052 1.558
2026/202713.536 2.130 3.121 3.794 4.491 0 0 0 0 0 0 0 0
Totale 111.474